FindTrial
Sign In

A Clinical Study to Evaluate the Effectiveness of BJain s Omeo Anaemia Syrup in Improving Nutritional Anaemia Among Women of Reproductive Age Group.

A Single-Site, Single-Arm, Prospective Clinical Study to Assess the Role of BJain s Omeo Anemia Syrup in Cases of Nutritional Anemia in Females of Reproductive Age Group. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/083541
Enrollment
41
Registered
2025-03-26
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E611- Iron deficiency

Interventions

Intervention1: BJain Omeo Anemia Syrup: Dosage: 10 mL, twice daily after meals Duration: 3 months Control Intervention1: NOT APPLICABLE: NOT APPLICABLE

Sponsors

BJain Pharmaceuticals Pvt. Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed with nutritional anemia with Hb less than 12 g/dL. Willing to provide informed consent and comply with the study protocol.

Exclusion criteria

Exclusion criteria: Pregnant or breastfeeding women. Chronic conditions affecting hemoglobin e.g., thalassemia. Known allergy to the investigational product. Any past surgeries in 6 months.

Design outcomes

Primary

MeasureTime frame
Change in hemoglobin levels.Timepoint: It will be assessed at 1 month, 2nd month and 3rd month at each follow up.—

Secondary

MeasureTime frame
Change in fatigue scores using the Fatigue Severity Scale (FSS).Timepoint: Participants will be assessed at baseline, at 2 months, at the end of the 3-months study period.—

Countries

India

Contacts

Public ContactDr Kiran

BJain Pharmaceuticals Pvt. Ltd.

research@bjainpharma.com7982487900

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026